A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer

被引：0
|
作者：
Zhao, Weihong
Zhang, Zheng
Zhang, Yadi
Chen, Yimeng
Zhu, Yimin
Liu, Chuanling
Shao, Jiakang
Zhang, Li
Liu, Mei
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Peoples Liberat Army Med Coll, Beijing, Peoples R China
[3] Nankai Univ, Sch Med, Tianjin, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Med Oncol, Xian, Peoples R China
[5] Chinese Peoples Liberat Army, Gen Hosp, Med Ctr 5, Dept Med Oncol, Beijing, Peoples R China
[6] Chinese Peoples Liberat Army, Gen Hosp, Med Ctr 1, Dept Med Oncol, Beijing, Peoples R China
[7] Chinese Peoples Liberat Army, Gen Hosp, Med Ctr 6, Dept Pathol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13090
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Tan, Qiaorui
    Chi, Yajing
    Su, Mu
    Zhou, Jinxing
    Zhou, Dongdong
    Zheng, Fangchao
    Man, Xiaochu
    Sun, Shujuan
    Huang, Jie
    Li, Huihui
    FRONTIERS IN GENETICS, 2023, 14
  • [32] Immune checkpoint inhibition in early-stage triple-negative breast cancer
    Varma, Revati
    Wright, Matthew
    Abraham, Jame
    Kruse, Megan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (11) : 1225 - 1238
  • [33] HDAC inhibition modulates immune checkpoint pathway in triple-negative breast cancer
    Barberio, Manuela Terranova
    Thomas, Scott
    Ali, Niwa
    Pawlowska, Nela
    Park, Jeenah
    Rosenblum, Michael D.
    Budillon, Alfredo
    Munster, Pamela N.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [34] A real-world study on the clinical value of apatinib-based regimens in metastatic triple-negative breast cancer
    Wei, H. W.
    Qi, C.
    Kun, S.
    Xi, W.
    Jian, H.
    Jian, L.
    Li, W.
    Fan, W.
    Chen, X.
    Ni, L.
    Yi, H.
    Lan, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S360 - S360
  • [35] Efficacy and Safety of Immune Checkpoint Inhibitors in Triple-negative Breast Cancer: A Study Based on 41 Cohorts Incorporating 6558 Participants
    Wu, Qing
    Wu, Chunlan
    Xie, Xianhe
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (02) : 29 - 42
  • [36] Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors
    Katuwal, Nar Bahadur
    Park, Nahee
    Pandey, Kamal
    Kang, Min Sil
    Hong, Sa Deok
    Ghosh, Mithun
    Kim, Seul-Gi
    Cho, Young Bin
    Hur, Jin
    Kim, Seung Ki
    Moon, Yong Wha
    ANTICANCER RESEARCH, 2023, 43 (01) : 85 - 95
  • [37] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [38] Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges
    Uchimiak, Katarzyna
    Badowska-Kozakiewicz, Anna M.
    Sobiborowicz-Sadowska, Aleksandra
    Deptala, Andrzej
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [39] Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges
    Uchimiak, Katarzyna
    Badowska-Kozakiewicz, Anna M.
    Sobiborowicz-Sadowska, Aleksandra
    Deptala, Andrzej
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [40] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
    Qureshi, Sadaf
    Chan, Nancy
    George, Mridula
    Ganesan, Shridar
    Toppmeyer, Deborah
    Omene, Coral
    BIOMARKER INSIGHTS, 2022, 17
12345